2
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Breast Neoplasms
74
Colorectal Neoplasms
41
Central Nervous System Neoplasms
37
Colonic Neoplasms
36
Rectal Neoplasms
34
Glioblastoma
23
Carcinoma, Non-Small-Cell Lung
21
Gliosarcoma
20
Stomach Neoplasms
18
Lung Neoplasms
18
Pancreatic Neoplasms
16
Head and Neck Neoplasms
16
Sarcoma
14
Ovarian Neoplasms
14
Squamous Cell Carcinoma of Head and Neck
13
Prostatic Neoplasms
12
Neoplasm Metastasis
11
Melanoma
11
Esophageal Neoplasms
11
Carcinoma, Ovarian Epithelial
11
Carcinoma, Intraductal, Noninfiltrating
11
Astrocytoma
11
Fallopian Tube Neoplasms
10
Brain Neoplasms
10
Uterine Cervical Neoplasms
9
Kidney Neoplasms
9
Breast Carcinoma In Situ
9
Liver Neoplasms
8
Breast Neoplasms, Male
8
Adenocarcinoma Of Esophagus
8
Interventions
Blood Specimen Collection
29
Reverse Transcriptase Polymerase Chain Reaction
7
Flow Cytometry
7
Surgical Procedures, Operative
4
Liquid Biopsy
4
cabazitaxel
3
Trastuzumab
3
Propofol
3
Carboplatin
3
Bevacizumab
3
Standard of Care
2
Spinal Puncture
2
Sevoflurane
2
Positron Emission Tomography Computed Tomography
2
Pirinitramide
2
Neoadjuvant Therapy
2
Morphine
2
Laparoscopy
2
Hematologic Tests
2
Gemcitabine
2
Folfox protocol
2
Epirubicin
2
Drug Therapy
2
Docetaxel
2
Cyclophosphamide
2
Cisplatin
2
Cetuximab
2
Capecitabine
2
Aspirin
2
Anesthesia, General
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplastic Cells, Circulating
×
Chemotherapy, Adjuvant
×
Clear all
NCT04902937
2023-11-28
CETC
University of Jena
Recruiting
200 enrolled